PEDIAPRED (prednisolone sodium phosphate) by Alcon is clinical pharmacology naturally occurring glucocorticoids (hydrocortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. First approved in 1986.
Drug data last refreshed 3h ago · AI intelligence enriched 2w ago
PEDIAPRED is an oral solution formulation of prednisolone sodium phosphate, a synthetic glucocorticoid used primarily in pediatric populations for anti-inflammatory and immunosuppressive effects. It treats a broad spectrum of inflammatory and autoimmune conditions by inhibiting inflammatory processes and suppressing immune cell production. The sodium phosphate salt enables rapid absorption and higher peak plasma levels compared to tablet formulations, making it particularly suitable for pediatric dosing.
Product nearing loss of exclusivity with moderate competitive pressure (30/100); brand teams should prepare for transition management and generic erosion strategies.
CLINICAL PHARMACOLOGY Naturally occurring glucocorticoids (hydrocortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. Their synthetic analogs are primarily used for their potent anti-inflammatory effects in disorders of many…
Worked on PEDIAPRED at Alcon? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on PEDIAPRED offers experience in a mature, LOE-stage branded product with established market position but declining innovation opportunity. Career growth requires strong commercial acumen in competitive defense, pricing strategy, and stakeholder retention rather than product-driven innovation or clinical development.